Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115186) titled 'An Observational Study on the Safety and Efficacy of Immunotherapy Combined With Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma' on Dec. 23, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Chongqing University Three Gorges Hospital(Chongqing Three Gorges Central Hospital)
Condition:
Esophageal cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-25
Target Sample Size: Observation group:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=29100...